CERS2 and cardiomyopathy: Intriguingly, although these cells have not been treated with any external compounds aside from the siRNA, it appears the HCMs with silenced CERS2 are developing an unhealthy cardiomyocyte phenotype, supported by a similar upregulation of pathways altered in human cardiomyopathy.